全球傷寒抗體檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計傷寒抗體檢測市場將從 2025 年的 17.9 億美元成長到 2034 年的 49.2 億美元，2026 年至 2034 年的複合年成長率為 11.89%。

受發展中國家傷寒發生率上升的推動，全球傷寒抗體檢測市場正穩定成長。準確快速的診斷檢測對於適當的治療和疾病管理至關重要。人們對感染疾病預防意識的提高也促進了市場成長。

關鍵成長要素包括快速診斷試劑盒和檢查室免疫檢測的進步。促進早期發現的公共衛生措施和免疫接種計劃正在推動市場需求。農村地區醫療保健服務的普及也促進了檢測率的提高。此外，政府對感染疾病監測的支持也在推動市場擴張。

展望未來，檢測靈敏度的提高和照護現場解決方案的廣泛應用預計將對市場產生積極影響。新興經濟體對醫療基礎設施的投資將創造新的機會。各公司正致力於開發經濟高效且易於使用的檢測套組。鑑於感染疾病監測的重要性依然不變，全球傷寒抗體檢測市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球傷寒抗體檢測市場：按類型分類

• 市場分析、洞察與預測
• 血清學檢測
• 核酸增幅檢查
• 聚合酵素鏈鎖反應檢測

第5章 全球傷寒抗體檢測市場：依技術分類

• 市場分析、洞察與預測
• 酵素免疫分析法（ELISA）
• 快速診斷測試
• 蛋白質印跡法

第6章 全球傷寒抗體檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 參考測試機構
• 診斷中心
• 家庭測試

第7章 全球傷寒抗體檢測市場：依樣本類型分類

• 市場分析、洞察與預測
• 血液樣本
• 血清樣本
• 血漿樣本

第8章：全球傷寒抗體檢測市場：依應用領域分類

• 市場分析、洞察與預測
• 臨床診斷
• 研究與開發
• 流行病學研究

第9章 全球傷寒抗體檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • BioRad Laboratories
  • Diagnostic BioSystems
  • Hoffmann-La Roche
  • Hycult Biotech
  • Medmix
  • Zhejiang Dian Diagnostics
  • VivaDiag
  • Roche Holding
  • Siemens Healthineers
  • Grifols
  • Meridian Bioscience
  • Wako Pure Chemical Industries
  • Thermo Fisher Scientific
  • Adaltis

The Typhoid Antibody Testing Market size is expected to reach USD 4.92 Billion in 2034 from USD 1.79 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The Global Typhoid Antibody Testing Market is growing steadily due to rising incidence of typhoid fever in developing regions. Accurate and rapid diagnostic testing is essential for timely treatment and disease control. Increasing awareness about infectious disease prevention is supporting market growth.

Key growth drivers include advancements in rapid diagnostic kits and laboratory-based immunoassays. Public health initiatives promoting early detection and vaccination programs are strengthening demand. Expanding healthcare access in rural areas is also contributing to higher testing rates. Additionally, government support for infectious disease surveillance is supporting market expansion.

Looking ahead, the market is expected to benefit from improved test sensitivity and point-of-care solutions. Emerging economies investing in healthcare infrastructure will present new opportunities. Companies are focusing on cost-effective and easy-to-use testing kits. As infectious disease monitoring remains critical, the Global Typhoid Antibody Testing Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Serologic Tests
• Nucleic Acid Amplification Tests
• Polymerase Chain Reaction Tests

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests
• Western Blotting

By End User

• Hospitals
• Reference Laboratories
• Diagnostic Centers
• Homecare Testing

By Sample Type

• Blood Samples
• Serum Samples
• Plasma Samples

By Application

• Clinical Diagnosis
• Research and Development
• Epidemiological Studies

COMPANIES PROFILED

• Abbott Laboratories, BioRad Laboratories, Diagnostic BioSystems, HoffmannLa Roche, Hycult Biotech, Medmix, Zhejiang Dian Diagnostics, VivaDiag, Roche Holding, Siemens Healthineers, Grifols, Meridian Bioscience, Wako Pure Chemical Industries, Thermo Fisher Scientific, Adaltis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Serologic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Polymerase Chain Reaction Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Diagnostic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Western Blotting Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Homecare Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. Blood Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Serum Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Plasma Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Clinical Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Epidemiological Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Technology
  • 9.2.3 By End User
  • 9.2.4 By Sample Type
  • 9.2.5 By Application
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Technology
  • 9.3.3 By End User
  • 9.3.4 By Sample Type
  • 9.3.5 By Application
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Technology
  • 9.4.3 By End User
  • 9.4.4 By Sample Type
  • 9.4.5 By Application
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Technology
  • 9.5.3 By End User
  • 9.5.4 By Sample Type
  • 9.5.5 By Application
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Technology
  • 9.6.3 By End User
  • 9.6.4 By Sample Type
  • 9.6.5 By Application
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL TYPHOID ANTIBODY TESTING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 BioRad Laboratories
  • 11.2.3 Diagnostic BioSystems
  • 11.2.4 Hoffmann-La Roche
  • 11.2.5 Hycult Biotech
  • 11.2.6 Medmix
  • 11.2.7 Zhejiang Dian Diagnostics
  • 11.2.8 VivaDiag
  • 11.2.9 Roche Holding
  • 11.2.10 Siemens Healthineers
  • 11.2.11 Grifols
  • 11.2.12 Meridian Bioscience
  • 11.2.13 Wako Pure Chemical Industries
  • 11.2.14 Thermo Fisher Scientific
  • 11.2.15 Adaltis